Terms: = Skin cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
211 results:
1. Hyaluronic acid-based injectable formulation developed to mitigate metastasis and radiation-induced skin fibrosis in breast cancer treatment.
Wang YC; Shueng PW; Hu CY; Tung FI; Chen MH; Liu TY
Carbohydr Polym; 2024 Jul; 336():122136. PubMed ID: 38670762
[TBL] [Abstract] [Full Text] [Related]
2. The impact of mental health on health-related quality of life in patients with nf2-related schwannomatosis.
Freier A; Lawson McLean AC; Loeschner D; Rosahl SK; Kruse J
Sci Rep; 2024 Mar; 14(1):6934. PubMed ID: 38521834
[TBL] [Abstract] [Full Text] [Related]
3. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J; Zimmermann N; Zell T; Rünger A; Heidrich I; Geidel G; Smit DJ; Hansen I; Abeck F; Schadendorf D; Eggermont A; Puig S; Hauschild A; Gebhardt C
Eur J Cancer; 2024 May; 202():113989. PubMed ID: 38518535
[TBL] [Abstract] [Full Text] [Related]
4. Auditory brainstem implants for hearing rehabilitation in nf2-schwannomatosis: A systematic review and single-arm meta-analysis.
Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
[TBL] [Abstract] [Full Text] [Related]
5. Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.
Nagel A; Huegel J; Petrilli A; Rosario R; Victoria B; Hardin HM; Fernandez-Valle C
Oncogene; 2024 Mar; 43(13):921-930. PubMed ID: 38336988
[TBL] [Abstract] [Full Text] [Related]
6. Improved sensitivity for detection of pathogenic variants in familial
Perez-Becerril C; Burghel GJ; Hartley C; Rowlands CF; Evans DG; Smith MJ
J Med Genet; 2024 Apr; 61(5):452-458. PubMed ID: 38302265
[TBL] [Abstract] [Full Text] [Related]
7. Stereotactic Radiosurgery and Radiotherapy for Vestibular schwannoma in nf2-Related schwannomatosis.
Shrivastava M; Emmanouil B; Mathew R; Halliday D; Parry A; Halliday J; Mackeith S
Laryngoscope; 2024 May; 134(5):2364-2371. PubMed ID: 37983868
[TBL] [Abstract] [Full Text] [Related]
8. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
[TBL] [Abstract] [Full Text] [Related]
9. Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.
Debs P; Belzberg A; Blakeley J; Fayad L; Langmead S; Little E; Romo C; Schatz K; Slobogean B; Ahlawat S
Skeletal Radiol; 2024 May; 53(5):909-916. PubMed ID: 37950060
[TBL] [Abstract] [Full Text] [Related]
10. Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials.
Staedtke V; Anstett K; Bedwell D; Giovannini M; Keeling K; Kesterson R; Kim Y; Korf B; Leier A; McManus ML; Sarnoff H; Vitte J; Walker JA; Plotkin SR; Wallis D
Clin Trials; 2024 Feb; 21(1):51-66. PubMed ID: 37937606
[TBL] [Abstract] [Full Text] [Related]
11. Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study.
Stassen RC; Mulder EEAP; Mooyaart AL; Francken AB; van der Hage J; Aarts MJB; van der Veldt AAM; Verhoef C; Grünhagen DJ
Eur J Surg Oncol; 2023 Dec; 49(12):107249. PubMed ID: 37907016
[TBL] [Abstract] [Full Text] [Related]
12. schwannomatosis: a Realm Reborn: year one.
Planet M; Kalamarides M; Peyre M
Curr Opin Oncol; 2023 Nov; 35(6):550-557. PubMed ID: 37820090
[TBL] [Abstract] [Full Text] [Related]
13. Culture of attenuated
Ahmed SG; Oliva G; Shao M; Mekalanos JJ; Brenner GJ
Hum Vaccin Immunother; 2023 Aug; 19(2):2262639. PubMed ID: 37786375
[TBL] [Abstract] [Full Text] [Related]
14. The SWI/SNF Complex in Neural Crest Cell Development and Disease.
Fountain DM; Sauka-Spengler T
Annu Rev Genomics Hum Genet; 2023 Aug; 24():203-223. PubMed ID: 37624665
[TBL] [Abstract] [Full Text] [Related]
15. schisandrin B Inhibits Cell Viability and Malignant Progression of Melanoma Cells
Chen J; Zhang L; Pu Y; Chen Y; Li Y; Pan X; Chen J
Anticancer Agents Med Chem; 2023; 23(15):1765-1773. PubMed ID: 37622448
[TBL] [Abstract] [Full Text] [Related]
16. CP-GEP (merlin) gene expression profiling: can my melanoma patient forgo sentinel lymph node biopsy?
Quattrocchi E; Meves ES; Meves A
Ital J Dermatol Venerol; 2023 Aug; 158(4):292-301. PubMed ID: 37539500
[TBL] [Abstract] [Full Text] [Related]
17. Extremely rare pediatric primary scrotum tumor: spermatic cord hemolymphangioma for a case report and literature review.
Liu L; Xiao Y; Yue X; Wang Q
World J Surg Oncol; 2023 Jul; 21(1):226. PubMed ID: 37495989
[TBL] [Abstract] [Full Text] [Related]
18. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract] [Full Text] [Related]
19. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract] [Full Text] [Related]
20. Targeted Therapies in the Treatment of Vestibular schwannomas: Current State and New Horizons.
Welling DB
Otolaryngol Clin North Am; 2023 Jun; 56(3):543-556. PubMed ID: 37024334
[TBL] [Abstract] [Full Text] [Related]
[Next]
